AFT Pharmaceuticals (NZX:AFT)
ASX announcement history & article coverage
Transparent by design.
Announcments by AFT Pharmaceuticals (NZX:AFT) are listed here, whether we covered it or not. Where we've written an article, you'll see it linked directly. Where we haven't, the filing is still shown so nothing is hidden from view. If you think a particular announcement deserved editorial coverage and was overlooked, you can flag it for review and our team will take a look.
Sept 26 2QFY27 Investor Update
Maxigesic IV Licensed for Japan
Results of AFT Pharmaceuticals Limited’s 2026 Annual Shareholders’ Meeting
AFT Chair's Address at the ASM 31 July 2026
AFT 2026 Annual Meeting Presentation
AFT Chair David Flacks to retire before the next ASM
AFT R&D portfolio offers multi-billion-dollar market potential
AFT Market Release Investor Day Presentation 28 July 2026
Pitt St Research initiates coverage on AFT Pharmaceuticals
ScomaraTM Tentative Approval by US FDA
FDA Grants Tentative Approval for AFT's Scomara with US Launch Delayed Until 2029
